Aug. 21, 2026
Mutsamudu, Comoros, August 21st, 2026, Chainwire
MEXC, a pioneer in 0-fee digital asset trading, has listed the MRNAON/USDT trading pair on Spot, giving users a new opportunity to access U.S. stock markets as part of its expanding lineup of Ondo tokenized stock offerings.
Moderna, Inc., a U.S.-based biotechnology company known for its mRNA vaccine platform, has seen its shares rally sharply in recent trading. On August 19, 2026, Moderna and Merck announced that their investigational personalized mRNA cancer vaccine, used in combination with Keytruda, met the primary endpoint of a late-stage melanoma trial, with the combination regimen meeting the main study goal of significantly extending the time patients lived without their melanoma returning, compared with Keytruda alone. Moderna’s stock price soared 177% that day, delivering a substantial blow to short sellers, marking one of its largest single-session gains on record and drawing renewed market attention to the company’s expanding pipeline beyond vaccines.
The MRNAON/USDT trading pair went live on Spot at 09:00 on August 20, 2026 (UTC). Deposits are open, with withdrawals enabled from 09:00 on August 21, 2026 (UTC).
